Effects of etomidate on complications related to intubation and on mortality in septic shock patients treated with hydrocortisone: a propensity score analysis
Open Access
- 1 January 2012
- journal article
- research article
- Published by Springer Science and Business Media LLC in Critical Care
- Vol. 16 (6), R224
- https://doi.org/10.1186/cc11871
Abstract
Endotracheal intubation in the ICU is associated with a high incidence of complications. Etomidate use is debated in septic shock because it increases the risk of critical illness-related corticosteroid insufficiency, which may impact outcome. We hypothesized that hydrocortisone, administered in all septic shock cases in our ICU, may counteract some negative effects of etomidate. The aim of our study was to compare septic shock patients who received etomidate versus another induction drug both for short-term safety and for long-term outcomes. A single-center observational study was carried out in septic shock patients, treated with hydrocortisone and intubated within the first 48 hours of septic shock. Co-primary end points were life-threatening complications incidence occurring within the first hour after intubation and mortality during the ICU stay. Statistical analyses included unmatched and matched cohorts using a propensity score analysis. P < 0.05 was considered significant. Sixty patients in the etomidate cohort and 42 patients in the non-etomidate cohort were included. Critical illness-related corticosteroid insufficiency was 79% in the etomidate cohort and 52% in the non-etomidate cohort (P = 0.01). After intubation, life-threatening complications occurred in 36% of the patients whatever the cohort. After adjustment with propensity score analysis, etomidate was a protective factor for death in the ICU both in unmatched (hazard ratio, 0.33 (0.15 to 0.75); P < 0.01)) and matched cohorts (hazard ratio, 0.33 (0.112 to 0.988); P = 0.04). In septic shock patients treated with hydrocortisone, etomidate did not decrease life-threatening complications following intubation, but when associated with hydrocortisone it also did not impair outcome.Keywords
This publication has 45 references indexed in Scilit:
- The Absence of Adrenal Gland Enlargement during Septic Shock Predicts MortalityAnesthesiology, 2011
- Corticosteroids for severe sepsis: an evidence-based guide for physiciansAnnals of Intensive Care, 2011
- Hemodynamic parameters to guide fluid therapyAnnals of Intensive Care, 2011
- LIPOTEICHOIC ACID-INDUCED TNF-α AND IL-6 GENE EXPRESSIONS AND OXIDATIVE STRESS PRODUCTION IN MACROPHAGES ARE SUPPRESSED BY KETAMINE THROUGH DOWNREGULATING TOLL-LIKE RECEPTOR 2-MEDIATED ACTIVATION OF ERK1/2 AND NFκBShock, 2010
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesJournal of Clinical Epidemiology, 2008
- One single dose of etomidate negatively influences adrenocortical performance for at least 24 h in children with meningococcal sepsisIntensive Care Medicine, 2007
- Effect of induction agent on vasopressor and steroid use, and outcome in patients with septic shockCritical Care, 2007
- Chart Reviews In Emergency Medicine Research: Where Are The Methods?Annals of Emergency Medicine, 1996
- Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in SepsisChest, 1992
- Inhibition of Adrenal Steroidogenesis by the Anesthetic EtomidateNew England Journal of Medicine, 1984